1.68 Voxeletor with Dr. Olson & Humanizing Cancer, Defining Cancer, and more with Dr. David Steensma

OncologyMedicineHealth Policy
Written By Kerrington .

We begin this week's episode by breaking down the recent phase III trial on voxeletor in sickle cell disease with Dr. Sven Olson of OHSU. Next, we feature guest Dr. David Steensma of the Dana-Farber Cancer Institute in a far-reaching interview on being well-read, running a small lab, humanizing cancer, learning from our past use of erythropoiesis-stimulating agents, understanding the headache of contract research organizations, defining cancer, and more!

Kerrington .
Previous

2.01 Selinexor, ECHELON-2, Parachutes, Tumor-Treating Fields, & MedTwitter
Next

1.67 MONALEESA-7 and the Cost of Cancer Drugs with Dr. Stacie Dusetzina